**3.3 Statins**

The use of statins (HMG-CoA inhibitors) has shown in various studies to improve biochemical and histologic findings in NAFLD/NASH and slow down the progress of fibrosis. These results are attributed to the decrease of the levels of cholesterol and triglycerides, achieved by using statins, as well as their anti-inflammatory properties (**Figure 5**). Moreover, they decrease the cardiovascular risk associated with fatty liver disease [16].
